FindTrial
Sign In

Relationship between prescription methods and local control rate in stereotactic body radiotherapy for early-stage lung cancer: systematic review

Relationship between prescription methods and local control rate in stereotactic body radiotherapy for early-stage lung cancer: systematic review - Relationship between prescription methods and local control rate in stereotactic body radiotherapy for early-stage lung cancer: systematic review

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000045014
Enrollment
Unknown
Registered
2021-08-01
Start date
2021-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

None listed

Sponsors

Ofuna Chuo Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: We will include studies in which dose prescription methods and local control rate were described. Articles with at least 25 cases and a median follow-up duration of at least 15 months was included.Articles were published as full reports. Non-English reports will be excluded.

Exclusion criteria

Exclusion criteria: Articles including metastasis or articles which biologically effective dose and local control rate are not determined on a one-to-one basis will be excluded.

Design outcomes

Primary

MeasureTime frame
Correlation coefficient between biologically effective dose and local control.—

Countries

Japan

Contacts

Public ContactTakahisa Eriguchi

Ofuna Chuo Hospital Radiation Oncology Center

eriguchitakahisa@gmail.com0467452111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026